Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Mar 18:8:200.
doi: 10.3389/fbioe.2020.00200. eCollection 2020.

Antioxidant Nanotherapies for the Treatment of Inflammatory Diseases

Chen-Wen Li  1 , Lan-Lan Li  1   2 , Sheng Chen  3 , Jian-Xiang Zhang  1 , Wan-Liang Lu  4
Affiliations
Review

Antioxidant Nanotherapies for the Treatment of Inflammatory Diseases

Chen-Wen Li et al. Front Bioeng Biotechnol. .

Abstract

Reactive oxygen species (ROS) are essential in regulating various physiological functions. However, overproduction of ROS is implicated in the pathogenesis of various inflammatory diseases. Antioxidant therapy has thus represented an effective strategy for the treatment of oxidative stress relevant inflammatory diseases. Conventional anti-oxidative agents showed limited in vivo effects owing to their non-specific distribution and low retention in disease sites. Over the past decades, significant achievements have been made in the development of antioxidant nanotherapies that exhibit multiple advantages such as excellent pharmacokinetics, stable anti-oxidative activity, and intrinsic ROS-scavenging properties. This review provides a comprehensive overview on recent advances in antioxidant nanotherapies, including ROS-scavenging inorganic nanoparticles, organic nanoparticles with intrinsic antioxidant activity, and drug-loaded anti-oxidant nanoparticles. We highlight the biomedical applications of antioxidant nanotherapies in the treatment of different inflammatory diseases, with an emphasis on inflammatory bowel disease, cardiovascular disease, and brain diseases. Current challenges and future perspectives to promote clinical translation of antioxidant nanotherapies are also briefly discussed.

Keywords: ROS; antioxidant nanotherapies; inflammatory diseases; nanoparticles; oxidative stress.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Schematic, characterization, and in vivo evaluation of CeO2 nanoparticles (NPs). (A) Schematic illustration of therapeutic mechanisms of CeO2NPs. (B) High-resolution transmission electron microscopy (HR-TEM) photomicrograph at low (43,000×) magnification revealing loose CeO2NPs agglomerates. (C) High magnification image (400,000×) of individual 4 nm CeO2NPs with spherical shape. (D) (Left) The HR-TEM image of single CeO2 NP showing the spherical morphology; (middle) atomistic simulation of CeO2NP with a characteristic fluorite-like electronic structure; (right) FFT of the selected nanoparticle with indicated atomic planes. (E) TEM image of liver tissue obtained from a CCl4-treated rat receiving vehicle and a CCl4-treated rat receiving CeO2NPs. Hepatocyte intracellular space containing mitochondria (M), organelles, fat droplets (asterisk), glycogen inclusions (arrow head), and aggregates of CeO2NPs (arrows). (F) Effect of CeO2NPs on hepatic steatosis, fibrogenic and infiltrating cells. Reproduced with permission from Oró et al. (2016).
Figure 2
Figure 2
Characterization and antioxidative activity of manganese-based nanoparticles. (A,B) Scanning electron microscopy (SEM) (A) and TEM (B) images of Mn3O4 nanoparticles with flower-like morphology (Mnf). (C–E) A comparison of CAT (C), glutathione peroxidase (D), and SOD (E)-like activity of Mnf with other metal oxide nanoparticles. (F) TEM image of Mn3O4 nanoparticles synthesized via a hydrothermal method. (G–I) Dependence between the elimination of •O2− (G), •OH (H), H2O2 (I) and concentrations of Mn3O4 and CeO2 nanoparticles. (J) In vivo fluorescence imaging of mice with PMA-induced ear inflammation after treatment with Mn3O4 nanoparticles. Images in (A–E) are reproduced with permission from Singh et al. (2017). Images in (F–J) are reproduced with permission from Yao et al. (2018).
Figure 3
Figure 3
Design and preparation broad-spectrum ROS-scavenging nanoparticles for treatment of acute lung injury (ALI). (A) Schematic illustration of engineering of a broad-spectrum ROS-scavenging material and its nanoparticles based on functionalized β-CD. (B) The synthetic route of β-CD conjugated with Tempol (Tpl) and PBAP units (TPCD). CDI, 1,1-carbonyldiimidazole; DMAP, 4-dimethylaminopyridine; TCD, Tpl-conjugated β-CD; PBAP, 4-(hydroxymethyl) phenylboronic acid pinacol ester. (C–H) Treatment of ALI with TPCD nanoparticles (i.e., TPCD NP) in mice. (C) The lung wet-to-dry weight ratios after different treatments. (D–G) The expression levels of TNF-α (D), IL-1β (E), and H2O2 (F) in bronchoalveolar lavage fluid from mice with LPS-induced ALI and subjected to different treatments. (G) Quantified neutrophil counts in pulmonary tissues of ALI mice. (H) H&E-stained pathological sections of lung tissues. Data are mean ± standard error (n = 6). *P < 0.05, **P < 0.01, ***P < 0.001. Reproduced with permission from Li et al. (2018).
Figure 4
Figure 4
Applications of the engineered exosomes loaded with CAT mRNA in Parkinson's disease. (A) Schematic illustration of protection against neurotoxicity in an in vitro experimental model of Parkinson's disease by CAT mRNA delivery. (B) Engineered exosome producer cells were subcutaneously implanted with Matrigel in living mice. (C) Immunostaining result of tyrosine hydroxylase (TH)-positive neurons. Scale bars, 500 μm. (D) Attenuation of neuroinflammation caused by systemic LPS injection with catalase mRNA delivery in vivo. Reproduced with permission from Kojima et al. (2018). *p < 0.05, **p < 0.01; n.s., no significance.
Figure 5
Figure 5
A proresolving peptide nanotherapy for site-specific treatment of inflammatory bowel disease. (A,B) Schematic illustration of engineering of a ROS-responsive peptide nanotherapy (AON) (A) and targeted treatment of colitis (B). (C,D) TEM (C) and SEM (D) images of AON. Scale bars, 200 nm. (E) Selective accumulation of AON in the inflamed colons of mice with acute colitis. (F) Representative mini-endoscopic images of colons from colitic mice at day 7 after different treatments. ON, blank nanoparticles based on the ROS-responsive material of PBAP-conjugated β-CD (i.e., OxbCD); APN, Ac2-26-containing nanoparticles based on a non-responsive polymer PLGA. Reproduced with permission from Li C. et al. (2019).
Figure 6
Figure 6
Engineering of different inflammation-responsive nanotherapies for targeted treatment of restenosis. (A) Design of inflammation-triggerable nanoparticles. (B) Evans Blue staining indicates successful establishment of injury in the carotid artery. (C) DHE-stained cryosections showing oxidative stress in injured carotid arteries. The image at day 0 was acquired from the sample immediately collected after injury. (D) The levels of hydrogen peroxide in the carotid artery with or without injury. (E) H&E stained histological sections of carotid arteries isolated from rats subjected to various treatments. Scale bars, 200 μm (the upper panel), 50 μm (the lower panel). PLGA NP, Ac-bCD NP, and Ox-bCD NP represents nanoparticles based on a non-responsive polymer PLGA, a pH-responsive material of acetelated β-CD, and a ROS-responsive material of PBAP-conjugated β-CD, respectively. Data are mean ± standard deviation (n = 3). ***P < 0.001. Reproduced with permission from Feng et al. (2016).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Alaarg A., Perez-Medina C., Metselaar J. M., Nahrendorf M., Fayad Z. A., Storm G., et al. . (2017). Applying nanomedicine in maladaptive inflammation and angiogenesis. Adv. Drug Deliv. Rev. 119, 143–158. 10.1016/j.addr.2017.05.009 - DOI - PMC - PubMed
    1. Alexescu T., Tarmure S., Negrean V., Cosnarovici M., Ruta V., Popovici I., et al. (2019). Nanoparticles in the treatment of chronic lung diseases. J. Mind Med. Sci. 6, 224–231. 10.22543/7674.62.P224231 - DOI
    1. Ali S. S., Hardt J. I., Dugan L. L. (2008). Sod activity of carboxyfullerenes predicts their neuroprotective efficacy: a structure-activity study. Nanomed. Nanotechnol. 4, 283–294. 10.1016/j.nano.2008.05.003 - DOI - PMC - PubMed
    1. Andersen J. K. (2004). Oxidative stress in neurodegeneration: Cause or consequence? Nat. Med. 10, S18–S25. 10.1038/nrn1434 - DOI - PubMed
    1. Apostolova N., Victor V. M. (2015). Molecular strategies for targeting antioxidants to mitochondria: therapeutic implications. Antioxid. Redox Signal. 22, 686–729. 10.1089/ars.2014.5952 - DOI - PMC - PubMed